𝔖 Bobbio Scriptorium

✦ LIBER ✦

Ipilimumab emerges as first treatment to improve melanoma survival

✍ Scribed by JANE SALODOF MACNEIL

Book ID: 118628308
Publisher: Frontline Medical Communications, Inc.
Year: 2010
Tongue: English
Weight: 52 KB
Volume: 7
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(11)70588-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Treatment Strategies to Impro

First-Line Treatment Strategies to Improve Survival in Patients with Advanced Colorectal Cancer

✍ Sharlene Gill, Dr Richard M. Goldberg 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 251 KB

643 IMPROVED EFFICIENCY OF HCC SCREENING

643 IMPROVED EFFICIENCY OF HCC SCREENING IS MAINLY DUE TO THE INTRODUCTION OF RFA AS THE FIRST LINE CURATIVE TREATMENT

✍ G. Nkontchou; A. Mounir; Q. Cao; N. Ganne-Carrié; V. Grando; D. Roulot; J.C. Tri 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

4004 Cetuximab plus capecitabine as firs

4004 Cetuximab plus capecitabine as first-line treatment for elderly patients (pts) with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS status – the TTD-06–01 Spanish Cooperative Group trial

✍ F. Rivera; C. Gravalos; B. Massutí; J. Puente; E. Marcuello; M. Valladares; V. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB